Portage biotech reports business and strategic update

Westport, conn., jan. 04, 2024 (globe newswire) -- portage biotech inc. (nasdaq: prtg), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, today announced the outcome from the company's comprehensive review of its pipeline in the context of the current capital raising market conditions.

ATON Ratings Summary

ATON Quant Ranking